Glivec: Phase II

In an open label international Phase II trial of 532 CML patients who failed therapy with interferon, preliminary results of 388 patients at 3 months showed that Glivec

Read the full 282 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE